Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-07-08

Clinical Trial Update: A Study to Check How Often People Treated With Darvadstrocel for Crohn's Disease Are Diagnosed With Cancer

View source ↗

Summary

A clinical trial evaluating cancer incidence in people treated with darvadstrocel for Crohn's disease with complex perianal fistula has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darvadstrocel (darvadstrocel)

Snippet

Sponsor: Takeda | Conditions: Crohn Disease, Complex Perianal Fistula | Status: WITHDRAWN